The Effect of Using Mobile Technology-Based Methods That Record Food or Nutrient Intake on Diabetes Control and Nutrition Outcomes: A Systematic Review
Abstract
:1. Introduction
2. Methods
2.1. Eligibility Criteria
2.2. Search Terms
2.3. Study Selection
2.4. Data Extraction and Quality Assessment
2.5. Synthesis of Results
3. Results
4. Discussion
5. Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
Appendix A
Author | Fasting BGL | BMI, Weight and Anthropometry | Lipids | Food Intake | Satisfaction and Useability | Uptake and Engagement |
---|---|---|---|---|---|---|
Drion et al., 2015 [15] | - | - | - | - | DBEES app rated 77 using the System Usability Scale (>70 is acceptable). No specific evaluation of the dietary component. | - |
Forjouh et al., 2014 [17] | - | “modest reductions” in BMI in all groups. data not provided. | - | PDA group ate more high fat foods (p < 0.004). Data not reported. | - | Interaction with dietary record component specifically not reported. CDSMP + PDA group—verage of 359 entries/year. PDA group—average of 342 entries/year. |
Quinn et al., 2011 [18] | - | - | No change in TAG, LDL or HDL within groups, with no difference between groups (p not reported). Significant reduction in total cholesterol within the coach group but no change within other groups and no difference in change between groups (p not reported). | - | - | - |
Rossi et al., 2013 [16] | Significant reduction within control group, no change within intervention group. No significant difference in change between groups (p = 0.07). | No change in weight within intervention or control group. No difference in change in weight between groups (p = 0.85). | No change within groups and no significant difference in change between groups for total cholesterol (p = 0.47), HDL (p = 0.71) or TAG (p = 0.22). Significant reduction within intervention group but not control group, with no difference in change between groups for LDL (p = 0.61). | - | - | - |
Waki et al., 2014 [19] | Significant difference in change between groups (p = 0.019) favouring the intervention. | No difference in change in BMI between groups (p = 0.062). | No difference in change in HDL (p = 0.36), LDL (p = 0.43) or total cholesterol (p = 0.24) between groups. | - | Most patients responded favourably to satisfaction questions. | Average time spent using the system was 22.5 min/day (relates to whole app). On average 40% recorded dietary data and 69% photographed the meal. Recording of dietary data declined from 54% to 27% of patients between the first 2 weeks and the last 2 weeks. This was also observed for photos of meals—77% first 2 weeks, 51% last 2 weeks. |
Zhou et al., 2016 [20] | Significant reduction within both groups, with significant difference in change between groups in favour of the intervention (p < 0.01). | No change in weight, BMI or waist circumference within either group, and no difference in change between groups (p not reported). | No change in LDL within either group and no difference in change between groups (p not reported). | - | 84% of patients in the intervention group were satisfied with the app. | |
Tsang 2001 [23] | - | - | - | - | 95% reported the system was easy to use. 63% reported it was useful in evaluating eating habits. 36% experienced technical problems. | Variation in the frequency of data transmission and analysis: 15% ≥7/week, 11% 5–6/week, 21% 3–4/week, 37% 1–2/week, 15% <1/week. The majority (73%) of participants transmitted data for analysis for 3 meals per occasion. |
Rossi et al., 2010 [22] | No change within either group, and no difference in change between groups (p = 0.13). | Significant increase in weight within the control group but no change within the intervention group. No difference in change in weight between groups (p = 0.22). | No change within either group for TAG, but significant difference in change between groups in favour of the intervention (p = 0.04). No change within either group and no difference in change between groups for total cholesterol (p = 0.33) or LDL (p = 0.79). Significant increase in HDL within control group but no change within intervention group and no difference in change between groups (p = 0.14). | - | - | Interaction with dietary record component specifically not reported. The median (range) number of text messages sent by each patient during the study was 52 (6–75), whereas the number of text messages sent by the clinician was 39 (22–70). |
Holman et al., 2014 [21] | - | No change in weight within any groups. No difference in change in weight between groups (p not reported). | - | No difference between groups in change in intake of fruits, vegetables, meat, chocolate and fish (p not reported). | - | Interaction with dietary record component specifically not reported. 39% high users in FTA group and 34% in FTA HC group (where high user ≥5 BGL measurements and ≥ 50 interactions with the diary). Those aged ≥63 years used the app significantly more than younger participants (p = 0.045). |
References
- Statista. Number of smartphone users worldwide from 2014 to 2020. Available online: https://www.statista.com/statistics/330695/number-of-smartphone-users-worldwide/ (accessed on 24 October 2016).
- Statista. Number of Tablet Users Worldwide from 2013 to 2020. Available online: https://www.statista.com/statistics/377977/tablet-users-worldwide-forecast/ (accessed on 24 October 2016).
- International Diabetes Federation. Bringing Research in Diabetes to Global Environments and Systems, 2015. Available online: http://www.idf.org/BRIDGES/map/china (accessed on 17 November 2016).
- Centers for Disease Control and Prevention. A snapshot diabetes in the United States. Available online: http://www.cdc.gov/diabetes/pubs/statsreport14/diabetes-infographic.pdf (accessed on 17 November 2016).
- Guariguata, L.; Whiting, D.; Weil, C.; Unwin, N. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res. Clin. Pract. 2011, 94, 322–332. [Google Scholar] [CrossRef] [PubMed]
- American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014, 37, S14–S80. [Google Scholar]
- Marcolino, M.S.; Maia, J.X.; Alkmim, M.B.M.; Boersma, E.; Ribeiro, L. Telemedicine applications in the care of diabetes patients: Systematic review and meta-analysis. PLoS ONE 2013, 8, e79246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rollo, M.E.; Ash, S.; Lyons-Wall, P.; Russell, A.W. Evaluation of a mobile phone image-based dietary assessment method in adults with type 2 diabetes. Nutrients 2015, 7, 4897–4910. [Google Scholar] [CrossRef] [PubMed]
- Brzan, P.P.; Rotman, E.; Pajnkihar, M.; Klanjsek, P. Mobile applications for control and self management of diabetes: A systematic review. J. Med. Syst. 2016, 40, 210. [Google Scholar] [CrossRef] [PubMed]
- Stephens, J.; Allen, J. Mobile phone interventions to increase physical activity and reduce weight: A systematic review. J Cardiovasc. Nurs. 2013, 28, 320. [Google Scholar] [CrossRef] [PubMed]
- Campbell, J.; Porter, J. Dietary mobile apps and their effect on nutritional indicators in chronic renal disease: A systematic review. Nephrology 2015, 20, 744–751. [Google Scholar] [CrossRef] [PubMed]
- Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. BMJ 2009, 399, b2535. [Google Scholar] [CrossRef] [PubMed]
- Shamseer, L.; Moher, D.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015, 349, g7647. [Google Scholar] [CrossRef] [PubMed]
- Academy of Nutrition and Dietetics. Evidence analysis manual: Steps in the Academy Evidence Analysis Process, 2012. Available online: https://www.andeal.org/files/Docs/2012_Jan_EA_Manual.pdf (accessed on 2 September 2016).
- Drion, I.; Pameijer, L.R.; van Dijk, P.R.; Groenier, K.H.; Kleefstra, N.; Bilo, H.J. The effects of a mobile phone application on quality of life in patients with type 1 diabetes mellitus: A randomized controlled trial. J. Diabetes Sci. Technol. 2015, 9, 1086–1091. [Google Scholar] [CrossRef] [PubMed]
- Rossi, M.C.; Nicolucci, A.; Lucisano, G.; Pellegrini, F.; Di Bartolo, P.; Miselli, V.; Anichini, R.; Vespasiani, G. Impact of the “diabetes interactive diary” telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: A randomized clinical trial in type 1 diabetes. Diabetes Technol. Thers. 2013, 15, 670–679. [Google Scholar] [CrossRef] [PubMed]
- Forjuoh, S.N.; Bolin, J.N.; Huber, J.C., Jr.; Vuong, A.M.; Adepoju, O.E.; Helduser, J.W.; Begaye, D.S.; Robertson, A.; Moudouni, D.M.; Bonner, T.J.; et al. Behavioral and technological interventions targeting glycemic control in a racially/ethnically diverse population: A randomized controlled trial. BMC Public Health 2014, 14, 71. [Google Scholar] [CrossRef] [PubMed]
- Quinn, C.C.; Shardell, M.D.; Terrin, M.L.; Barr, E.A.; Ballew, S.H.; Gruber-Baldini, A.L. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011, 34, 1934–1942. [Google Scholar] [CrossRef] [PubMed]
- Waki, K.; Fujita, H.; Uchimura, Y.; Omae, K.; Aramaki, E.; Kato, S.; Lee, H.; Kobayashi, H.; Kadowaki, T.; Ohe, K. Dialbetics: A novel smartphone-based self-management support system for type 2 diabetes patients. J. Diabetes Sci. Technol. 2014, 8, 209–215. [Google Scholar] [CrossRef] [PubMed]
- Zhou, W.; Chen, M.; Yuan, J.; Sun, Y. Welltang—A smart phone-based diabetes management application-improves blood glucose control in Chinese people with diabetes. Diabetes Res. Clin. Pract. 2016, 116, 105–110. [Google Scholar] [CrossRef] [PubMed]
- Holmen, H.; Torbjørnsen, A.; Wahl, K.A.; Jenum, K.A.; Småstuen, C.M.; Årsand, E.; Ribu, L. A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2: One-year results from the Norwegian randomized controlled trial renewing health. JMIR mHealth uHealth 2014, 2, e57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rossi, M.C.E.; Nicolucci, A.; Di Bartolo, P.; Bruttomesso, D.; Girelli, A.; Ampudia, F.J.; Kerr, D.; Ceriello, A.; Mayor, C.D.L.Q.; Pellegrini, F.; et al. Diabetes interactive diary: A new telemedicine system enabling flexible diet and insulin therapy while improving quality of life. An open-label, international, multicenter, randomized study. Diabetes Care 2010, 33, 109–115. [Google Scholar] [CrossRef] [PubMed]
- Tsang, M.W.; Mok, M.; Kam, G.; Jung, M.; Tang, A.; Chan, U. Improvement in diabetes control with a monitoring system based on a hand-held, touch-screen electronic diary. J. Telemed. Telecare 2001, 7, 47–50. [Google Scholar] [CrossRef] [PubMed]
Author | Drion et al., 2015 [15] | Forjouh et al., 2014 [17] | Quinn et al., 2011 [18] | Rossi et al., 2013 [16] | Waki et al., 2014 [19] | Zhou et al., 2016 [20] | Tsang 2001 [23] | Rossi et al., 2010 [22] | Holman et al., 2014 [21] |
Study Design | RCT | RCT (4 arms) | Cluster RCT (4 arms) | RCT | RCT | RCT | Cross over study | RCT | RCT (3 arms) |
Duration | 3 months | 12 months | 12 months | 6 months | 3 months | 3 months | 3 months (each group) | 6 months | 1 year |
Setting | Netherlands, 1 outpatient clinic | United States, 7 outpatient clinics | United States, 26 primary care practices | Italy, 12 outpatient clinics | Japan, 1 hospital | China, 1 hospital endocrinology department | Hong Kong, 1 outpatient clinic | Multinational. 3 outpatient clinics in Italy, 2 in England and 2 in Spain | Norway, 2 study centres, local clinics, diabetes courses and advertisements |
Population and Characteristics Mean (SD) | Adults with T1DM. 33 (21) years, 63% male, BMI 26 (4) kg/m2, baseline HbA1c 62 (16) mmol/mol. | Adults with T2DM and HbA1c ≥7.5%. 58 (11) years, 45% male, BMI 34 (7) kg/m2, baseline HbA1c 9.3 (1.6) mmol/mol. | Adults (18–64 years) with T2DM and HbA1c ≥7.5%. 53 years, 49.7% male, 76% obese, baseline HbA1c 9.4 mmol/mol. | Adults with T1DM and HbA1c ≥7.5%. 34 (10) to 38 (10) years, 46 to 19% male, BMI 24 (4) to 25 (4) kg/m2, baseline HbA1c not reported. | Adults with T2DM. 57 (10) years, 66% male, 50% BMI <25, baseline HbA1c 7.1 (0.9)% | Adults with T1DM or T2DM. 53.5 (12.4) to 55.0 (13.1) years, 54%–60% male, BMI 23 (4) kg/m2, baseline HbA1c 9.8 (2.5) to 9.9 (2.4)% | Not reported. 30 (8) to 35 (8) years, 63% male, BMI 22 (3) to 26 (6) kg/m2, baseline HbA1c 8.5 (1.8) to 8.8 (1.8)% | Adults with T1DM. 35 (9) to 36 (9) years, 41%–44% male, baseline HbA1c 8.2 (0.8) to 8.4 (0.7)% | Adults with T2DM and HbA1c ≥7.1%. 57 (12) years, 59% male, BMI 32.7 (6.1) kg/m2, baseline HbA1c 8.2 (1.1)% |
Sample Size (n) Completion Rate | 63 (98%) | 376 (70%) | 213 (76%) | 127 (88%) | 54 (100%) | 100 (100%) | 20 (95%) | 130 (92%) | 151 (79%) |
Intervention/s Description | Diabetes Under Control (DBEES) mobile app linked to a personal web portal. Captured BGL, medication, PA and CHO intake. | Intervention 1 (PDA) —Diabetes Pilot™ on a PDA. Captured BGL, BP, medication, PA and dietary intake using a food database. Intervention 2 (PDA + CDSMP)–As above plus Chronic Disease Self Management Program 6 week group education program to increase self efficacy. | Intervention 1 (coach) —Patient coaching and clinician support system on mobile phone and web. Captured BGL, CHO intake, medication. | Diabetes Interactive Diary (DID) software on mobile phone. CHO/insulin bolus calculator. Captured BGL and CHO intake, recorded using a “food atlas”. | DialBetics with FoodLog on mobile phone. Captured BGL, BP, pedometer readings and food intake recorded with photos, voice and text messages and linked to a database. | Welltang mobile app. Captured BGL, CHO intake, medications, notes. | Diabetes monitoring system (DMS) on hand held device. Captured BGL and food intake using a food database. | Diabetes Interactive Diary (DID) software on mobile phone. CHO/insulin bolus calculator. Captured BGL and CHO intake using a list of foods with pictures and quantities to select from. | Intervention 1 Few Touch Application (FTA) mobile app. Captured BGL, food intake, PA, goal setting and other information. |
Intervention 2 (CPP) coach + primary care provider portal—As above plus clinicians had access to data. | |||||||||
Intervention 2 Few Touch Application plus health counselling (FTA HC)—As above, plus 5 phone based sessions with diabetes nurse educator to improve self management. | |||||||||
Intervention 3 (CPDS) coach + primary care provider portal + decision support—Coach program as above plus clinicians had access to analysed data linked to standards. | |||||||||
Communication between Patients and Clinician | Not reported | Not reported | Yes, as above | Yes | Yes | Yes | Yes | Yes | Not reported |
Analysis of Food or Nutrient Data | Not reported | Not reported | Yes, as above | Not reported | Yes | Not reported | Yes | Yes | Unclear |
Control/s Description | Not reported | Control 1—Usual care; Control 2—CDSMP only (as described above) | Usual care | Usual care—standard education | Control group—unclear | Usual care—monthly clinic visits | Usual care—consultations with clinicians | Usual care—standard education | Usual care |
HbA1c | No significant difference in change between groups (p not reported). Median (IQR) change. Control: 1 (−4–6) mmol/mol; Intervention: 1 (−1–2) mmol/mol. | No significant treatment effect (p = 0.771). Change Control: −0.7%; CDSMP: −1.1%; PDA: −0.7%, CDSMP + PDA: −1.1% | Significantly greater reduction in CPDS group compared to control (p = 0.001) and coach group compared to control (p = 0.027). No significant difference in change between CPP group and control (p = 0.40). Mean (95% CI) change coach: −1.6 (−2.3–−1.0)% CPP: −1.2 (−1.8–−0.5)% CPDS: −1.9 (−2.3–−1.5)% control: −0.7 (−1.1–−0.3)% | No significant difference in change between groups (p = 0.73). mean (SD) change DID group: 0.49 (0.11)%; Control: 0.48 (0.11)% | Significant difference in change between groups (p = 0.015). Mean change DialBeltics group: −0.4%; Control: 0.1% | Significantly greater reduction in the intervention group (p < 0.001). Mean change Welltang group: −1.95%; Control: −0.79% | Significant reduction associated with the intervention (p < 0.019). mean (95% CI) difference 0.825% (0.155–1.50). | No difference in change between groups (p = 0.68). mean change (SD). DID group: −0.4 (0.9)%; Control: −0.5 (1)% | No difference in change between groups (p not reported). Mean (95% CI) change. FTA: −0.31 (−0.67–0.05)% FTA HC: −0.15 (−0.58–0.29)%; Control: −0.16 (−0.5–0.18)% |
Author/Year | Quality Rating a | Validity Items b | Example of Reasons for Downgrading | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |||
Drion et al., 2015 [15] | Neutral | √ | x | √ | √ | x | x | √ | √ | √ | √ | Devices not provided hence biasing sample; methods were unclear |
Forjouh et al., 2014 [17] | Positive | √ | √ | √ | √ | x | √ | √ | x | √ | √ | Methods used in the intention to treat analysis not described |
Holman et al., 2014 [21] | Positive | √ | √ | √ | √ | x | √ | √ | x | √ | √ | Methods used in the intention to treat analysis not described |
Quinn et al., 2011 [18] | Neutral | √ | x | √ | √ | x | √ | √ | √ | √ | √ | All participants needed internet and email access. |
Rossi et al., 2010 [22] | Neutral | √ | x | √ | √ | x | √ | √ | √ | √ | x | Participants were required to be familiar with mobile phones, and be in possession of, a mobile phone card. |
Rossi et al., 2013 [16] | Positive | √ | √ | √ | √ | x | √ | √ | x | √ | √ | Methods used in the intention to treat analysis not described |
Tsang et al., 2001 [23] | Negative | x | x | x | √ | x | x | x | x | √ | √ | Selection of study groups and statistical analysis not clearly reported. |
Waki et al., 2014 [19] | Neutral | √ | x | x | √ | x | x | √ | x | √ | x | Methods used in the intention to treat analysis not described |
Zhou et al., 2016 [20] | Neutral | √ | x | √ | √ | x | √ | √ | x | x | √ | Prospective participants were excluded if they were unable to use a smartphone. Statistical analysis was unclear |
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Porter, J.; Huggins, C.E.; Truby, H.; Collins, J. The Effect of Using Mobile Technology-Based Methods That Record Food or Nutrient Intake on Diabetes Control and Nutrition Outcomes: A Systematic Review. Nutrients 2016, 8, 815. https://doi.org/10.3390/nu8120815
Porter J, Huggins CE, Truby H, Collins J. The Effect of Using Mobile Technology-Based Methods That Record Food or Nutrient Intake on Diabetes Control and Nutrition Outcomes: A Systematic Review. Nutrients. 2016; 8(12):815. https://doi.org/10.3390/nu8120815
Chicago/Turabian StylePorter, Judi, Catherine E. Huggins, Helen Truby, and Jorja Collins. 2016. "The Effect of Using Mobile Technology-Based Methods That Record Food or Nutrient Intake on Diabetes Control and Nutrition Outcomes: A Systematic Review" Nutrients 8, no. 12: 815. https://doi.org/10.3390/nu8120815
APA StylePorter, J., Huggins, C. E., Truby, H., & Collins, J. (2016). The Effect of Using Mobile Technology-Based Methods That Record Food or Nutrient Intake on Diabetes Control and Nutrition Outcomes: A Systematic Review. Nutrients, 8(12), 815. https://doi.org/10.3390/nu8120815